GlassScriptPhysician profile
Ahmed Khan
NPI 1770915670
$8,182.99
in general payments reported to CMS, 2019-2025
33 companies · $506 in 2025
The $506 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,227 · 2020: $290 · 2021: $653 · 2022: $3,094 · 2023: $200 · 2024: $2,214 · 2025: $506.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,643 · Food and Beverage: $1,277.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,642.69 |
| Food and Beverage | $1,277.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimvie INC. | $1,764.18 | 2022 | |
| Intuitive Surgical, INC. | $1,742.26 | 2024 | |
| Atricure, INC. | $826.41 | 2019 | |
| Edwards Lifesciences Corporation | $657.34 | 2019-2024 | Mitris Resilia Mitral Valve |
| Baxter Healthcare | $570.88 | 2019-2022 | |
| Gilead Sciences, INC. | $299.96 | 2023-2025 | Yeztugo |
| Abiomed | $295.45 | 2020-2025 | |
| Merck Sharp & Dohme LLC | $251.19 | 2022-2023 | Verquvo |
| Getinge USA Sales, LLC | $196.29 | 2022 | |
| Abbott Laboratories | $186.42 | 2022 | |
| Angiodynamics, INC. | $181.49 | 2021 | |
| Globus Medical, INC. | $167.87 | 2024 | Excelsius3d Imaging System |
| Inari Medical, INC. | $146.60 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| E.R. Squibb & Sons, L.L.C. | $119.96 | 2019-2021 | |
| Ethicon US, LLC | $112.38 | 2020 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $108.99 | 2021-2022 | |
| Amgen INC. | $94.85 | 2019-2023 | Repatha |
| Janssen Pharmaceuticals, INC | $87.27 | 2022 | |
| Penumbra, INC. | $78.20 | 2022 | |
| Pfizer INC. | $68.14 | 2021-2025 | |
| Cardiva Medical, INC. | $27.88 | 2025 | Cardiva Vascade 6/7f Vcs |
| Csl Behring | $24.93 | 2020 | |
| Novo Nordisk INC | $21.80 | 2023 | |
| Alnylam Pharmaceuticals INC. | $21.05 | 2021 | |
| Chiesi USA, INC. | $20.93 | 2022 | |
| Novartis Pharmaceuticals Corporation | $19.62 | 2022 | |
| Seagen INC. | $17.80 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.38 | 2020 | |
| Depuy Synthes Sales INC. | $16.32 | 2025 | Na |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $15.84 | 2021 | |
| Novocure INC. | $12.20 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $12.11 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ahmed Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.